Cargando…

Effect of Body Position, Exercise, and Sedation on Estimation of Pulmonary Artery Pressure in Dogs with Degenerative Atrioventricular Valve Disease

BACKGROUND: Severity of pulmonary hypertension (PH) in dogs is related to clinical signs and prognosis. HYPOTHESIS/OBJECTIVES: We hypothesized that Doppler echocardiographic (DE) indices of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) are influenced by independent factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhinehart, J.D., Schober, K.E., Scansen, B.A., Yildiz, V., Bonagura, J.D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697194/ https://www.ncbi.nlm.nih.gov/pubmed/28865107 http://dx.doi.org/10.1111/jvim.14814

Ejemplares similares

Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease
por: Chapel, E.H., et al.
Publicado: (2017)

Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy
por: Rohrbaugh, Michelle N., et al.
Publicado: (2020)

Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve disease
por: Oyama, Mark A., et al.
Publicado: (2023)

Effects of pimobendan on left atrial transport function in cats
por: Kochie, Samantha L., et al.
Publicado: (2020)

Pathologic Manifestations on Surgical Biopsy and Their Correlation with Clinical Indices in Dogs with Degenerative Mitral Valve Disease
por: Lee, J., et al.
Publicado: (2015)

The classical and alternative circulating renin‐angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease
por: Hammond, Hillary H., et al.
Publicado: (2023)

Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary‐care veterinary practices in the United Kingdom
por: Mattin, M. J., et al.
Publicado: (2018)

Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2019)

Short‐Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study
por: Chetboul, V., et al.
Publicado: (2017)

Long‐term Intrinsic Rhythm Evaluation in Dogs with Atrioventricular Block
por: Santilli, R.A., et al.
Publicado: (2016)

Effect of calibration methods on the accuracy of angiographic measurements during transcatheter procedures in dogs
por: Markovic, Lauren E., et al.
Publicado: (2018)

Effect of Fenoldopam Continuous Infusion on Glomerular Filtration Rate and Fractional Excretion of Sodium in Healthy Dogs
por: Kelly, K.L., et al.
Publicado: (2016)

Lidocaine for chemical cardioversion of orthodromic atrioventricular reciprocating tachycardia in dogs
por: Wright, Kathy N., et al.
Publicado: (2019)

Comparison of Forelimb and Hindlimb Systolic Blood Pressures and Proteinuria in Healthy Shetland Sheepdogs
por: Scansen, B.A., et al.
Publicado: (2014)

Pulmonary Vein‐to‐Pulmonary Artery Ratio is an Echocardiographic Index of Congestive Heart Failure in Dogs with Degenerative Mitral Valve Disease
por: Merveille, A.‐C., et al.
Publicado: (2015)

Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study
por: Besche, Beatrice, et al.
Publicado: (2020)

Brain diffusion tensor imaging in dogs with degenerative myelopathy
por: Lewis, Melissa J., et al.
Publicado: (2021)

Factors associated with disease progression in dogs with presumed preclinical degenerative mitral valve disease attending primary care veterinary practices in the United Kingdom
por: Mattin, Madeleine J., et al.
Publicado: (2018)

Association of Hypercalcemia Before Treatment With Hypocalcemia After Treatment in Dogs With Primary Hyperparathyroidism
por: Dear, J.D., et al.
Publicado: (2017)

Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease
por: Wilshaw, Jenny, et al.
Publicado: (2021)

Transatrial stenting for long‐term management of cardiac tumor obstruction of the right atrium in 3 dogs
por: Weisse, Chick, et al.
Publicado: (2020)

Right atrial thrombus formation in a dog after successful electrical cardioversion for atrial fibrillation
por: Karn, Marta, et al.
Publicado: (2023)

Diagnosis and management of dogs with degenerative myelopathy: A survey of neurologists and rehabilitation professionals
por: Bouché, Teryn V., et al.
Publicado: (2023)

A pilot study investigating circulating trimethylamine N‐oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure
por: Karlin, Emily T., et al.
Publicado: (2018)

Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation
por: Wright, Kathy N., et al.
Publicado: (2018)

Evaluation of right ventricular diastolic function, systolic function, and circulating galectin‐3 concentrations in dogs with pulmonary stenosis
por: Winter, Randolph L., et al.
Publicado: (2023)

In vivo detection of microstructural spinal cord lesions in dogs with degenerative myelopathy using diffusion tensor imaging
por: Johnson, Philippa J., et al.
Publicado: (2020)

Utility of vertebral left atrial size and vertebral heart size to aid detection of congestive heart failure in dogs with respiratory signs
por: Ross, Evan S., et al.
Publicado: (2023)

Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
por: Blass, K.A., et al.
Publicado: (2014)

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial
por: Boswood, A., et al.
Publicado: (2016)

Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
por: Boswood, Adrian, et al.
Publicado: (2020)

Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
por: Kim, H.‐S., et al.
Publicado: (2016)

Effect of prior general anesthesia or sedation and antiseizure drugs on the diagnostic utility of wireless video electroencephalography in dogs
por: Parmentier, Thomas, et al.
Publicado: (2020)

Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease
por: Lam, Christopher, et al.
Publicado: (2021)

Sedation with dexmedetomidine is associated with transient gallbladder wall thickening and peritoneal effusion in some dogs undergoing abdominal ultrasonography
por: Seitz, Marc A., et al.
Publicado: (2021)

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study
por: Boswood, A., et al.
Publicado: (2017)

The Effect of the Canine ABCB1‐1Δ Mutation on Sedation after Intravenous Administration of Acepromazine
por: Deshpande, D., et al.
Publicado: (2016)

Echocardiographic evaluation of velocity ratio, velocity time integral ratio, and pulmonary valve area in dogs with pulmonary valve stenosis
por: Nishimura, Satoko, et al.
Publicado: (2018)

Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial
por: Wess, Gerhard, et al.
Publicado: (2020)

Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2‐12, in Healthy Dogs and Dogs with Clinical Recurrent UTI
por: Segev, G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b5m039nhgcveaj69vmmqean165